期刊文献+

布洛芬不良反应危险因素分析和判别(英文) 被引量:6

Risk factor analysis and discrimination of adverse drug reactions to ibuprofen
下载PDF
导出
摘要 目的 :观察分析布洛芬的不良反应和相关的危险因素。方法 :采用分层整群抽样 ,回顾性访问的方法调查了上海市 9家医院的风湿科门诊病人 ,采用R×C χ2 或Wilcoxon秩和检验进行单因素分析 ;采用logistic逐步回归进行多因素分析 ,分析引起布洛芬不良反应的相关因素 ,并建立判别方程。结果 :共 447位病人入选本次调查 ,其中有 1 4 4例(32 .2 % )发生不良反应。经过分析判别 ,单因素分析结果显示“合并用药史”、“疾病家族史”、“服用可乐的时间”、“与服药以前半年的健康状况比较”、“过去 4wk内感到心情抑郁的程度”、“在服药NSAIDs前 4wk内感到筋疲力尽的程度”、“觉得无助从而影响生活质量”、“觉得无法自控从而影响生活质量”、“觉得仇视从而影响生活质量”与不良反应的发生有关。进一步用logistic逐步回归分析显示 8个因子“合并用药史”、“吸烟史”、“能接受一些无法改变的事情”、“对服药前自身健康的总体评价”、“可乐的服药时间”、“与服药以前半年的健康状况比较”、“健康状况对活动影响 (第 1主成分 )”、“个人财务对生活的影响”与不良反应的发生相关。同时得出了引起布洛芬不良反应的相关因素以及判别方程并进行了敏感度和特异度分析。结论 AIM: To observe adverse drug reactions(ADRs) caused b y ibuprofen and analyze related risk factors. METHODS: By using stratified clu ster sampling, a retrospective survey was conducted on outpatients from the rheumatic departmen ts of 9 hospitals in Shanghai. Analytical methods including univariate analysis and logistic stepwise regression were adopted to identify risk factors for ADRs induced by ibuprofen and to establish a discriminatory equation. RESULTS: Four hundred and forty-seven patients were enrolled in the survey, 144 (32.2 %) of which had ADRs to ibuprofen. Risk factors were identified and a discriminatory equation was established based on the statistical results. CO NCLUSION: The occurrence of ibuprofen ADRs is affected by multiple factors. The sensitivity and specificity of logistic stepwise regression analysis discriminat ory equation are low. This indicates that maybe only part of the risk factors h ave been discovered in the study.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2004年第2期67-72,共6页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家食品和药品监督管理局药物再评价中心和药物不良反应监测中心资助项目 (BK PJ 0 3 0 1)~~
关键词 布洛芬 LOGISTIC模型 消炎药 非甾类 回顾性研究 药物不良反应 ibuprofen logistic models anti-inflammatory agents, non-steroidal retrospe ctive studies adverse drug reaction
  • 相关文献

参考文献13

  • 1[1]RAINSFORD KD. History and development of ibuprofen, in Rainsford KD(ed): A critical bibliographic Review[M]. London: Taylor and Francis, 1994. 1-24.
  • 2[2]GLYN V.Current issues on the safety of non-prescription NSAIDs[J]. Inflammopharmacology, 2001,9(12):43-49.
  • 3[3]MOORE N. Forty years of ibuprofen use[J]. Int J Clin Pract Suppl, 2003, 135(4):28-31.
  • 4[4]JAMES F, GRAUMLICH MD. Preventing gastrointestinal complications of NSAIDs[J]. Postgrad Med, 2001, 19(5):117-127.
  • 5[5]HAWKEY CJ. Cox-1 and cox-2 inhibitors[J]. Best Pract Res Clin Gastroenterol, 2001, 15(5):801-820.
  • 6[6]WOLFE MM. Risk factors associated with the development of gastroduodenal ulcer due to the use of NSAIDs[J]. Int J Clin Pract Suppl, 2003, 135 (4):32-37.
  • 7[7]HENRY D, McGETTIGAN P. Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs[J]. Int J Clin Pract Suppl, 2003, 135 (4):43-49.
  • 8[8]KELLSTEIN DE, WAKSMAN JA, FUREY SA, et al. The safety profile of nonprescription ibuprofen in multiple-dose use: a meta-analysis[J]. J Clin Pharmacol, 1999 , 39(5):520-532.
  • 9[9]SINGH G, TRIADAFILOPOULOS G. Epidemiology of NSAID induced gastrointestinal complications[J]. J Rheumatol, 1999, 26 Suppl 56:18-24.
  • 10[10]LICHETENSTEIN D, SYNGAL S, WLFE MM. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract[J]. Arthritis Rherm, 1995,38(1):5-18.

同被引文献39

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部